Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Seeman

Showing results (191-200 of 325) with videos related to

Pageof 33
Sort By:
European Journal of Pharmacology|August 29, 1980
Serotonin receptors in hippocampus and frontal cortexP Seeman, K Westman, D Coscina, et al.
Nature|June 24, 1976
Antipsychotic drug doses and neuroleptic/dopamine receptorsP Seeman, T Lee, M Chau-Wong, et al.
European Journal of Pharmacology|August 27, 1981
Assay for soluble dopamine receptors by the precipitation methodB Chan, B K Madras, A Davis, et al.
The Journal of Cell Biology|February 1, 1973
Membrane lesions in immune lysis: surface rings, globule aggregates and transient openingsG H Iles, P Seeman, D Naylor, et al.
European Neurology|January 1, 1990
Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophreniaR K Pearce, P Seeman, K Jellinger, et al.
Synapse (New York, N.Y.)|August 1, 1993
Dopamine receptors labelled by PHNOP Seeman, C Ulpian, R D Larsen, et al.
Journal of Neurochemistry|July 1, 1984
Dopamine receptor parameters detected by [3H]spiperone depend on tissue concentration: analysis and examplesP Seeman, C Ulpian, K A Wreggett, et al.
Advances in Biochemical Psychopharmacology|January 1, 1978
Brain receptors for dopamine and neurolepticsP Seeman, M Titeler, J Tedesco, et al.
Clinical Genetics|May 12, 2010
Clinical and in silico evidence for and against pathogenicity of 11 new mutations in the MPZ geneD Brozková, R Mazanec, J Haberlová, et al.
Brain Research|May 26, 1980
A neuroblastoma clone which has dopamine-sensitive adenylate cyclase but which lacks stereospecific binding sites for the neuroleptic [3H]spiperoneE J Hartley, K Spuhler, K N Prasad, et al.
Pageof 33

Showing results (191-200 of 325) with videos related to

Sort By:
Pageof 33
European Journal of Pharmacology|August 29, 1980
Serotonin receptors in hippocampus and frontal cortexP Seeman, K Westman, D Coscina, et al.
Nature|June 24, 1976
Antipsychotic drug doses and neuroleptic/dopamine receptorsP Seeman, T Lee, M Chau-Wong, et al.
European Journal of Pharmacology|August 27, 1981
Assay for soluble dopamine receptors by the precipitation methodB Chan, B K Madras, A Davis, et al.
The Journal of Cell Biology|February 1, 1973
Membrane lesions in immune lysis: surface rings, globule aggregates and transient openingsG H Iles, P Seeman, D Naylor, et al.
European Neurology|January 1, 1990
Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophreniaR K Pearce, P Seeman, K Jellinger, et al.
Synapse (New York, N.Y.)|August 1, 1993
Dopamine receptors labelled by PHNOP Seeman, C Ulpian, R D Larsen, et al.
Journal of Neurochemistry|July 1, 1984
Dopamine receptor parameters detected by [3H]spiperone depend on tissue concentration: analysis and examplesP Seeman, C Ulpian, K A Wreggett, et al.
Advances in Biochemical Psychopharmacology|January 1, 1978
Brain receptors for dopamine and neurolepticsP Seeman, M Titeler, J Tedesco, et al.
Clinical Genetics|May 12, 2010
Clinical and in silico evidence for and against pathogenicity of 11 new mutations in the MPZ geneD Brozková, R Mazanec, J Haberlová, et al.
Brain Research|May 26, 1980
A neuroblastoma clone which has dopamine-sensitive adenylate cyclase but which lacks stereospecific binding sites for the neuroleptic [3H]spiperoneE J Hartley, K Spuhler, K N Prasad, et al.
Pageof 33